163 related articles for article (PubMed ID: 34556494)
1. Intranasal Iloprost Prevents Tumors in a Murine Lung Carcinogenesis Model.
Tennis MA; Smith AJ; Dwyer-Nield LD; Keith RL
Cancer Prev Res (Phila); 2022 Jan; 15(1):11-16. PubMed ID: 34556494
[TBL] [Abstract][Full Text] [Related]
2. The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model.
Dwyer-Nield L; Hickey GA; Friedman M; Choo K; McArthur DG; Tennis MA; New ML; Geraci M; Keith RL
Cancer Prev Res (Phila); 2017 Nov; 10(11):671-679. PubMed ID: 28851689
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer Chemoprevention.
New ML; White CM; McGonigle P; McArthur DG; Dwyer-Nield LD; Merrick DT; Keith RL; Tennis MA
Cancer Prev Res (Phila); 2018 Oct; 11(10):643-654. PubMed ID: 30045935
[TBL] [Abstract][Full Text] [Related]
4. Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model.
Dwyer-Nield L; Keith RL; Tennis MA
STAR Protoc; 2022 Dec; 3(4):101750. PubMed ID: 36201319
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin reverses the cigarette smoke-induced decrease in pulmonary Frizzled 9 expression through miR-31.
Tennis MA; New ML; McArthur DG; Merrick DT; Dwyer-Nield LD; Keith RL
Sci Rep; 2016 Jun; 6():28519. PubMed ID: 27339092
[TBL] [Abstract][Full Text] [Related]
6. Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.
Nemenoff R; Meyer AM; Hudish TM; Mozer AB; Snee A; Narumiya S; Stearman RS; Winn RA; Weiser-Evans M; Geraci MW; Keith RL
Cancer Prev Res (Phila); 2008 Oct; 1(5):349-56. PubMed ID: 19138979
[TBL] [Abstract][Full Text] [Related]
7. Iloprost requires the Frizzled-9 receptor to prevent lung cancer.
Sompel K; Dwyer-Nield LD; Smith AJ; Elango A; Backos DS; Zhang B; Gross J; Ternyak K; Matsuda JL; Kopf K; Keith RL; Tennis MA
iScience; 2022 Jun; 25(6):104442. PubMed ID: 35707728
[TBL] [Abstract][Full Text] [Related]
8. Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.
Mascaux C; Feser WJ; Lewis MT; Barón AE; Coldren CD; Merrick DT; Kennedy TC; Eckelberger JI; Rozeboom LM; Franklin WA; Minna JD; Bunn PA; Miller YE; Keith RL; Hirsch FR
Cancer Prev Res (Phila); 2013 Feb; 6(2):100-8. PubMed ID: 23268837
[TBL] [Abstract][Full Text] [Related]
9. miR-520a-5p regulates Frizzled 9 expression and mediates effects of cigarette smoke and iloprost chemoprevention.
Smith AJ; Do P; Sompel K; Elango A; Tennis MA
Sci Rep; 2022 Feb; 12(1):2388. PubMed ID: 35149732
[TBL] [Abstract][Full Text] [Related]
10. Precision Cut Lung Slices as a Preclinical Model for Non-Small Cell Lung Cancer Chemoprevention.
Sompel K; Smith AJ; Hauer C; Elango AP; Clamby ET; Keith RL; Tennis MA
Cancer Prev Res (Phila); 2023 May; 16(5):247-258. PubMed ID: 36888650
[TBL] [Abstract][Full Text] [Related]
11. TARGETING THE PROSTACYCLIN/PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AXIS IN LUNG CANCER CHEMOPREVENTION.
Geraci MW
Trans Am Clin Climatol Assoc; 2018; 129():48-55. PubMed ID: 30166698
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.
Keith RL; Miller YE; Hudish TM; Girod CE; Sotto-Santiago S; Franklin WA; Nemenoff RA; March TH; Nana-Sinkam SP; Geraci MW
Cancer Res; 2004 Aug; 64(16):5897-904. PubMed ID: 15313935
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of lung tumorigenesis by intranasally administered diindolylmethane in A/J mice.
Qian X; Song JM; Melkamu T; Upadhyaya P; Kassie F
Carcinogenesis; 2013 Apr; 34(4):841-9. PubMed ID: 23239747
[TBL] [Abstract][Full Text] [Related]
14. Oral iloprost improves endobronchial dysplasia in former smokers.
Keith RL; Blatchford PJ; Kittelson J; Minna JD; Kelly K; Massion PP; Franklin WA; Mao J; Wilson DO; Merrick DT; Hirsch FR; Kennedy TC; Bunn PA; Geraci MW; Miller YE
Cancer Prev Res (Phila); 2011 Jun; 4(6):793-802. PubMed ID: 21636546
[TBL] [Abstract][Full Text] [Related]
15. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor 2-targeted chemoprevention of murine lung tumors.
Karoor V; Le M; Merrick D; Dempsey EC; Miller YE
Cancer Prev Res (Phila); 2010 Sep; 3(9):1141-7. PubMed ID: 20647338
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.
Keith RL; Karoor V; Mozer AB; Hudish TM; Le M; Miller YE
Lung Cancer; 2010 Oct; 70(1):37-42. PubMed ID: 20116128
[TBL] [Abstract][Full Text] [Related]
18. Effects of a stable prostacyclin analogue on platelet activity and on host immunocompetence in mice.
Costantini V; Fuschiotti P; Giampietri A; Allegrucci M; Agnelli G; Nenci GG; Fioretti MC
Prostaglandins; 1990 Jun; 39(6):581-99. PubMed ID: 1695382
[TBL] [Abstract][Full Text] [Related]
19. Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts.
Larsson-Callerfelt AK; Hallgren O; Andersson-Sjöland A; Thiman L; Björklund J; Kron J; Nihlberg K; Bjermer L; Löfdahl CG; Westergren-Thorsson G
Respir Res; 2013 Feb; 14(1):21. PubMed ID: 23406566
[TBL] [Abstract][Full Text] [Related]
20. Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.
Ahn JH; Lee KT; Choi YS; Choi JH
Prostaglandins Other Lipid Mediat; 2018 Jan; 134():47-56. PubMed ID: 29292033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
